US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist

3.9100
-0.0700-1.76%

Close Jun 7 16:00 ET

6.02MMarket Cap-1334P/E (TTM)

Xenetic Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5.16%-1.16M

11.46%-4.11M

-5.61%-793.03K

12.01%-949.63K

-74.11%-1.27M

47.19%-1.1M

1.93%-4.65M

48.52%-750.91K

-4.44%-1.08M

-0.29%-728.9K

Net income from continuing operations

-39.53%-1.2M

36.90%-4.13M

20.98%-1.17M

-31.29%-1.06M

60.67%-1.05M

46.25%-856.55K

-16.07%-6.55M

19.50%-1.48M

40.48%-804.02K

-141.46%-2.67M

Depreciation and amortization

----

--0

----

-23.78%27.04K

--0

-11.98%7.96K

9.89%9.61K

Other non cash items

----

--1.79M

--488.75K

--0

----

Change In working capital

86.88%-41.31K

38.43%-262.73K

144.63%303.9K

108.48%35.66K

-158.35%-287.55K

49.49%-314.74K

-192.52%-426.69K

-52.33%124.23K

-313.12%-420.57K

88.67%492.81K

-Change in prepaid assets

116.16%51.79K

53.99%-47.73K

469.94%876.73K

-232.75%-161.53K

-261.48%-442.5K

-22.10%-320.45K

-136.27%-103.74K

-168.00%-236.99K

291.48%121.67K

147.34%274.02K

-Change in payables and accrued expense

57.06%-93.09K

24.25%-263.57K

-1,261.14%-258.91K

186.36%197.18K

-93.08%14.95K

39.42%-216.79K

-176.12%-347.95K

-92.56%22.3K

-247.00%-228.33K

43.55%215.92K

-Change in other current assets

--0

94.32%48.58K

-192.62%-313.92K

--0

4,776.35%140K

7,849.91%222.5K

108.87%25K

187.46%338.92K

---313.92K

--2.87K

Cash from discontinued investing activities

Operating cash flow

-5.16%-1.16M

11.46%-4.11M

-5.61%-793.03K

12.01%-949.63K

-74.11%-1.27M

47.19%-1.1M

1.93%-4.65M

48.52%-750.91K

-4.44%-1.08M

-0.29%-728.9K

Investing cash flow

Cash flow from continuing investing activities

-500K

Net intangibles purchase and sale

----

--0

----

---500K

--0

----

Cash from discontinued investing activities

Investing cash flow

----

--0

----

---500K

--0

----

Financing cash flow

Cash flow from continuing financing activities

Cash from discontinued financing activities

Net cash flow

Beginning cash position

-31.41%8.98M

-28.21%13.1M

-29.41%9.78M

-28.15%10.73M

-25.76%11.99M

-28.21%13.1M

58.26%18.24M

-29.71%13.85M

60.83%14.93M

61.43%16.16M

Current changes in cash

-5.16%-1.16M

20.06%-4.11M

-5.61%-793.03K

12.01%-949.63K

-3.27%-1.27M

47.19%-1.1M

-176.63%-5.15M

48.52%-750.91K

-110.36%-1.08M

-69.08%-1.23M

End cash Position

-34.77%7.82M

-31.41%8.98M

-29.41%9.78M

-28.15%10.73M

-25.76%11.99M

-28.21%13.1M

-29.71%13.85M

60.83%14.93M

Free cash flow

-5.16%-1.16M

20.06%-4.11M

-5.61%-793.03K

12.01%-949.63K

-3.27%-1.27M

47.19%-1.1M

-8.63%-5.15M

48.52%-750.91K

-4.44%-1.08M

-69.08%-1.23M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5.16%-1.16M	11.46%-4.11M	-5.61%-793.03K	12.01%-949.63K	-74.11%-1.27M	47.19%-1.1M	1.93%-4.65M	48.52%-750.91K	-4.44%-1.08M	-0.29%-728.9K
Net income from continuing operations	-39.53%-1.2M	36.90%-4.13M	20.98%-1.17M	-31.29%-1.06M	60.67%-1.05M	46.25%-856.55K	-16.07%-6.55M	19.50%-1.48M	40.48%-804.02K	-141.46%-2.67M
Depreciation and amortization	----	--0	--0	--0	----	----	-23.78%27.04K	--0	-11.98%7.96K	9.89%9.61K
Other non cash items	----	----	----	----	----	----	--1.79M	--488.75K	--0	----
Change In working capital	86.88%-41.31K	38.43%-262.73K	144.63%303.9K	108.48%35.66K	-158.35%-287.55K	49.49%-314.74K	-192.52%-426.69K	-52.33%124.23K	-313.12%-420.57K	88.67%492.81K
-Change in prepaid assets	116.16%51.79K	53.99%-47.73K	469.94%876.73K	-232.75%-161.53K	-261.48%-442.5K	-22.10%-320.45K	-136.27%-103.74K	-168.00%-236.99K	291.48%121.67K	147.34%274.02K
-Change in payables and accrued expense	57.06%-93.09K	24.25%-263.57K	-1,261.14%-258.91K	186.36%197.18K	-93.08%14.95K	39.42%-216.79K	-176.12%-347.95K	-92.56%22.3K	-247.00%-228.33K	43.55%215.92K
-Change in other current assets	--0	94.32%48.58K	-192.62%-313.92K	--0	4,776.35%140K	7,849.91%222.5K	108.87%25K	187.46%338.92K	---313.92K	--2.87K
Cash from discontinued investing activities
Operating cash flow	-5.16%-1.16M	11.46%-4.11M	-5.61%-793.03K	12.01%-949.63K	-74.11%-1.27M	47.19%-1.1M	1.93%-4.65M	48.52%-750.91K	-4.44%-1.08M	-0.29%-728.9K
Investing cash flow
Cash flow from continuing investing activities		0	0	0			-500K	0	0
Net intangibles purchase and sale	----	--0	--0	--0	----	----	---500K	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	----	----	---500K	--0	--0	----
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position	-31.41%8.98M	-28.21%13.1M	-29.41%9.78M	-28.15%10.73M	-25.76%11.99M	-28.21%13.1M	58.26%18.24M	-29.71%13.85M	60.83%14.93M	61.43%16.16M
Current changes in cash	-5.16%-1.16M	20.06%-4.11M	-5.61%-793.03K	12.01%-949.63K	-3.27%-1.27M	47.19%-1.1M	-176.63%-5.15M	48.52%-750.91K	-110.36%-1.08M	-69.08%-1.23M
End cash Position	-34.77%7.82M	-31.41%8.98M	-31.41%8.98M	-29.41%9.78M	-28.15%10.73M	-25.76%11.99M	-28.21%13.1M	-28.21%13.1M	-29.71%13.85M	60.83%14.93M
Free cash flow	-5.16%-1.16M	20.06%-4.11M	-5.61%-793.03K	12.01%-949.63K	-3.27%-1.27M	47.19%-1.1M	-8.63%-5.15M	48.52%-750.91K	-4.44%-1.08M	-69.08%-1.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall